![Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F62334.jpg&w=3840&q=50)
BCMA CAR-T:从多发性骨髓瘤到轻链粉症
Ellen Lewis1,2, Victor Hugo Jimenez-Zepeda1,2,3
1Arthur Child Comprehensive Cancer Centre, Calgary, AB T2N 4N2, Canada.
Current oncology (Toronto, Ont.)
|August 27, 2025
概括
B细胞成熟抗原 (BCMA) 疗法在复发性/耐火性轻链粉症 (AL) 中具有前景. 本综述审查了BCMA导向治疗,包括CAR-T细胞治疗,将其疗效和耐受性与多发性骨髓瘤结局进行比较.
科学领域:
- 血液学
- 癌症学
- 免疫疗法
背景情况:
- 轻链粉症是一种罕见的,危及生命的血细胞疾病.
- 如果没有治疗,器官损伤和死亡风险很高.
- 对复发性/耐药性 (RR) AL粉样性缺乏最佳策略,没有FDA批准的治疗方法.
研究的目的:
- 对AL粉样性病的B细胞成熟抗原 (BCMA) 定向疗法的疗效和耐受性进行评估.
- 在BCMA导向治疗中强调CAR-T细胞治疗.
- 将AL氨基粉症的结果与复发性/耐药性多发性髓瘤 (RRMM) 的结果进行比较.
主要方法:
- 在AL氨基粉症中使用BCMA治疗的文献综述.
- 专注于CAR-T细胞治疗,抗体与药物结合物以及双特异性抗体.
- 与现有的RRMM治疗数据进行比较分析.
主要成果:
- 针对BCMA的疗法正在成为RR AL粉症的潜在治疗途径.
- CAR-T细胞疗法显示出潜力,目前正在对其应用进行研究.
- 来自RRMM的数据为评估AL氨基粉症的BCMA导向治疗疗效提供了基准.
结论:
- 针对BCMA的疗法,特别是CAR-T细胞疗法,代表了治疗RRAL粉样性粉症的前沿.
- 进一步的研究对于建立最佳治疗方案和扩大治疗选择至关重要.
- 从RRMM中翻译成功的结果为AL粉症治疗的发展提供了宝贵的见解.
相关概念视频
01:27Tumor Immunotherapy
660
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
660
02:57Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
02:50Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K